Lovir

Država: Novi Zeland

Jezik: engleski

Izvor: Medsafe (Medicines Safety Authority)

Aktivni sastojci:

Aciclovir 800mg;  

Dostupno od:

Douglas Pharmaceuticals Limited

INN (International ime):

Aciclovir 800 mg

Doziranje:

800 mg

Farmaceutski oblik:

Dispersible tablet

Sastav:

Active: Aciclovir 800mg   Excipient: Colloidal silicon dioxide Magnesium stearate Microcrystalline cellulose Pregelatinised maize starch Purified water Sodium starch glycolate

Jedinice u paketu:

Blister pack, 35 tablets

Razred:

Prescription

Tip recepta:

Prescription

Proizveden od:

Zhejiang Charioteer Pharmaceutical Co. Ltd

Terapijske indikacije:

· Treatment of Herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · Suppression (prevention of recurrences) of recurrent Herpes simplex infections in immune-competent patients. · Prophylaxis of Herpes simplex infections in immune-competent patients. · Treatment of acute Herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · Management of patients with severe AIDS who have a CD4 count of less than 50/µL. Studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced HIV disease. · Patients undergoing allogenic bone marrow transplantation who are at risk of developing CMV infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). Studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. In addition oral aciclovir provided effective prophylaxis for herpes virus disease.

Proizvod sažetak:

Package - Contents - Shelf Life: Blister pack, - 35 tablets - 36 months from date of manufacture stored at or below 25°C

Datum autorizacije:

1997-06-16

Uputa o lijeku

CONSUMER MEDICINE INFORMATION
LOVIR
_aciclovir _
200 mg, 400 mg and 800 mg dispersible tablets.
WHAT IS IN THIS LEAFLET
PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING LOVIR.
This
leaflet
answers
some
common
questions
about LOVIR 200 mg, 400 mg and 800 mg tablets.
It does not contain all the available information. It
does not take the place of talking to your doctor
or pharmacist.
All medicines have risks and benefits. Your doctor
has weighed the risks of you taking LOVIR against
the benefits they expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING LOVIR
200 MG, 400 MG AND 800 MG TABLETS, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE. YOU MAY
NEED TO READ IT AGAIN.
WHAT LOVIR TABLETS ARE USED FOR
LOVIR
tablets
contain
the
active
ingredient
aciclovir.
Aciclovir belongs to a group of medicines called
“anti-virals”. LOVIR works by stopping the herpes
virus being able to reproduce. The length and
severity of an outbreak of herpes is therefore
reduced. Long term use of LOVIR can reduce the
number
of
herpes
outbreaks
in
people
who
experience this condition often. LOVIR does not
get rid of the herpes virus from your body.
Your doctor may have prescribed LOVIR tablets for
another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT
WHY LOVIR HAS BEEN PRESCRIBED FOR YOU.
This medicine is available only with a doctor's
prescription.
BEFORE YOU TAKE LOVIR TABLETS
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE LOVIR IF YOU HAVE AN ALLERGY TO:
•
any medicine containing aciclovir or a class
of medicines called “anti-virals”.
•
any of the ingredients listed at the end of
this leaflet
Some of the symptoms of an allergic reaction may
include:
•
difficulty in breathing or wheezing
•
shortness of breath
•
swelling of the face, tongue, lips or
other parts of the body
•
hives on the skin, rash, or itching.
DO NOT TAKE THIS MEDICINE IF YOU ARE PREGNANT.
It may affect your developing baby if you take it
during pregnancy.
DO NOT BREASTFEED IF YOU ARE TAKING THIS MEDICINE.
T

Svojstava lijeka

1 | P a g e
NEW ZEALAND DATA SHEET
1.
PRODUCT NAME
LOVIR® Dispersible tablet, 200 mg
LOVIR® Dispersible tablet, 400 mg
LOVIR® Dispersible tablet, 800 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each LOVIR 200 mg Dispersible tablet contains aciclovir 200 mg.
Each LOVIR 400 mg Dispersible tablet contains aciclovir 400 mg.
Each LOVIR 800 mg Dispersible tablet contains aciclovir 800 mg.
EXCIPIENT(S) WITH KNOWN EFFECT
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
LOVIR 200 mg: White to off-white capsule shaped, biconvex uncoated
tablet with “200”
debossed on one side and “ACV” on the other side.
LOVIR 400 mg: White to off-white capsule shaped, biconvex uncoated
tablet with “400”
debossed on one side and “ACV” on the other side.
LOVIR 800 mg: White to off-white capsule shaped, biconvex uncoated
tablet with “800”
debossed on one side and “ACV” on the other side.
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
LOVIR Dispersible tablets are indicated for:
•
Treatment of Herpes simplex virus infections of the skin and mucous
membranes
including initial and recurrent genital herpes.
•
Suppression (prevention of recurrences) of recurrent Herpes simplex
infections in
immune-competent patients.
•
Prophylaxis of Herpes simplex infections in immune-compromised
patients.
•
Treatment of acute Herpes zoster (shingles) infections, for the
reduction of the duration
and severity of acute symptoms and rash, for the reduction of all
zoster-associated pain
and for the reduction of the incidence and duration of post-herpetic
neuralgia.
2 | P a g e
•
Management of patients with severe AIDS who have a CD4 count of less
than 50/μL.
Studies have shown that oral aciclovir given in conjunction with
anti-retroviral therapy
reduced mortality in patients with advanced HIV disease.
•
Patients undergoing allogenic bone marrow transplantation who are at
risk of
developing CMV infection while immunosuppressed (preceded by one
month’s
treatment with intravenous aciclovir). Stu